Janux Therapeutics, Bristol Myers enter up to $850 million deal to develop cancer drug
百时美施贵宝百时美施贵宝(US:BMY) Reuters·2026-01-22 20:38

公司与合作 - Janux Therapeutics宣布与百时美施贵宝达成合作 共同开发新型癌症治疗方法 [1] - 该消息推动Janux Therapeutics股价在盘前交易中上涨超过12% [1]

Bristol-Myers Squibb-Janux Therapeutics, Bristol Myers enter up to $850 million deal to develop cancer drug - Reportify